Sophia Antipolis, France

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, informs its shareholders that the ordinary general meeting was held on May 3, 2018 and all resolutions were approved. The extraordinary general meeting convened on first call could not be held as the quorum required by law was not reached.

The shareholders are thus convened on second call for an extraordinary general meeting on the same agenda on Thursday May 24, 2018 at 2:00 pm CET in the offices of BuroClub – Drakkar 2 – Bâtiment D – 2405 route des Dolines – 06560 Valbonne Sophia Antipolis – France.

The documents mentioned in articles R.225-73-1 of the French Code de commerce, including those to be presented at the general meeting, are available on the Company’s website www.nicox.com. These documents are also available to shareholders at the headquarters of the Company.

Shareholders may vote by proxy, by internet or by attending the shareholder meeting in person. A guide explaining how to vote, and notably how to vote by internet, is available on Nicox’s website. Shareholders may also contact the Company’s Investor Relations team at age2018@nicox.com for any question on the voting process. The proxy forms sent for the first call remain valid. Shareholders having requested to attend the May 3, 2018 extraordinary shareholder meeting may attend the May 24, 2018 meeting.